GLP-1 RA use in complicated diabetes: There is no clear evidence regarding the use of GLP-1 RA in acute myocardial infarction, although the use of these agents is encouraged in patients with asymptomatic and stable coronary artery disease (CAD)
Weivoda MM, Chew CK, Monroe DG, Farr JN, Atkinson EJ, Geske JR, et al
Clinical trial outcomes reflect structured study conditions, including defined eligibility criteria, medical supervision, and guided nutrition and activity plans
Topiramate is often started at a low dose and gradually increased to minimize side effects
According to the website, this includes guidance on administration, side effect management, and dose-related questions
Starting too early increases the risk of severe nausea and protein malabsorption